Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Mauro, Schechter"'
Autor:
Nathalia Mantovani Pena, Luiz Claudio Santana, James R Hunter, Vinicius Fontanesi Blum, Tania Vergara, Celso Gouvea, Elcio Leal, Nancy Bellei, Mauro Schechter, Ricardo Sobhie Diaz
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Predictors of the outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection remain to be fully determined. We evaluated selected viral characteristics and immunological responses that might predict and/or c
Externí odkaz:
https://doaj.org/article/00e5bdb6f9e141e99885ce0418a5b7c9
Autor:
Jasmini Alagaratnam, Wolfgang Stöhr, Elizabeth Hamlyn, Kholoud Porter, Jamie Toombs, Amanda Heslegrave, Henrik Zetterberg, Magnus Gisslén, Jonathan Underwood, Mauro Schechter, Pontiano Kaleebu, Giuseppe Tambussi, Sabine Kinloch, Jose M. Miro, Anthony D. Kelleher, Abdel Babiker, John Frater, Alan Winston, Sarah Fidler
Publikováno v:
Journal of Virus Eradication, Vol 10, Iss 2, Pp 100381- (2024)
Objective: Antiretroviral therapy (ART)-conferred suppression of HIV replication limits neuronal injury and inflammation. ART interruption tests efficacy in HIV cure trials and viral rebound after ART interruption may induce neuronal injury. We inves
Externí odkaz:
https://doaj.org/article/487cf33da3b34fe190f0b5145c56c047
Autor:
Ricardo Sobhie Diaz, James R. Hunter, Michelle Camargo, Danilo Dias, Juliana Galinskas, Isabela Nassar, Isaac Barbosa de Lima, Debora Bellini Caldeira, Maria Cecilia Sucupira, Mauro Schechter
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Since January 2017, the recommended first-line antiretroviral regimen in Brazil is the fixed-dose combination of tenofovir plus lamivudine with dolutegravir (TL + D). According to the literature, integrase resistance-associated mu
Externí odkaz:
https://doaj.org/article/62715bec300849ba85220960f0bf2641
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 27, Iss 5, Pp 102808- (2023)
Externí odkaz:
https://doaj.org/article/4e3ed98a90e849f6a997ddefcc3eb981
Autor:
Michael M. Lederman, Jeffrey Flier, Peter Hale, Ashley Haase, William Powderly, Peter Reiss, Guido Silvestri, Rafick Sekaly, Mirko Paiardini, Drew Weissman, Daniel Kuritzkes, Leonard Calabrese, Peter Agre, Gustavo Reyes-Teran, Alan Landay, Sharon Lewin, Douglas Richman, Paul Volberding, Peter Hunt, Mauro Schechter
Publikováno v:
Pathogens and Immunity, Vol 6, Iss 2 (2021)
On September 10, 2021, a special tribunal established by the French government launched an inquiry into the activities of former health minister Dr. Agnes Buzyn who was charged with “endangering the lives of others”. It is surprising to learn of
Externí odkaz:
https://doaj.org/article/e49ede9741cd4510a3ab9c62eeb806a3
Autor:
Elidamar Nunes de Carvalho Lima, Guilherme Leão Barros Martins, Ricardo Sobhie Diaz, Mauro Schechter, José Roberto Castilho Piqueira, João Francisco Justo
Publikováno v:
Pharmaceutics, Vol 14, Iss 10, p 2004 (2022)
Melanoma is an aggressive skin cancer that affects approximately 140,000 people worldwide each year, with a high fatality rate. Available treatment modalities show limited efficacy in more severe cases. Hence, the search for new treatment modalities,
Externí odkaz:
https://doaj.org/article/0b5c86a7b94540869e151eabad0de12d
Autor:
Nathalia Mantovani, Luiz Santana, James Hunter, Vinicius Blum, Tania Vergara, Celso Gouvea, Elcio Leal, Nancy Bellei, Mauro Schechter, Ricardo Diaz
Background: Predictors of the outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) infection remain to be fully determined. We evaluated selected viral characteristics and immunological responses that might predict and/or correlate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e6a808d2081c3ea21f60d1e28b724f0
https://doi.org/10.21203/rs.3.rs-2883452/v1
https://doi.org/10.21203/rs.3.rs-2883452/v1
Autor:
Holly Janes, Marshall D Brown, David V Glidden, Kenneth H Mayer, Susan P Buchbinder, Vanessa M McMahan, Mauro Schechter, Juan Guanira, Martin Casapia
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222183 (2019)
IntroductionDeveloping guidelines to inform the use of antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention in resource-limited settings must necessarily be informed by considering the resources and infrastructure needed for PrEP deliver
Externí odkaz:
https://doaj.org/article/8e335fda570043e692ab1ed0cc602769
Autor:
Oriol Mitjà, Andrea Alemany, Michael Marks, Jezer I Lezama Mora, Juan Carlos Rodríguez-Aldama, Mayara Secco Torres Silva, Ever Arturo Corral Herrera, Brenda Crabtree-Ramirez, José Luis Blanco, Nicolo Girometti, Valentina Mazzotta, Aniruddha Hazra, Macarena Silva, Juan José Montenegro-Idrogo, Kelly Gebo, Jade Ghosn, María Fernanda Peña Vázquez, Eduardo Matos Prado, Uche Unigwe, Judit Villar-García, Noah Wald-Dickler, Jason Zucker, Roger Paredes, Alexandra Calmy, Laura Waters, Cristina Galvan-Casas, Sharon Walmsley, Chloe M Orkin, Viviana Leiro, Lucila Marchetta, Patricia Fernandez Pardal, María Inés Figueroa, Pedro Cahn, Katharina Grabmeier-Pfistershammer, Agnes Libois, Laurens Liesenborghs, Beatriz Grinsztejn, Mauro Schechter, Alberto dos Santos de Lemos, Alvaro Furtado Costa, Simone Queiroz Rocha, José Valdez Madruga, Darrell H. S. Tan, Sharmistha Mishra, Shreya Shah, Camila Jorquera, Alberto Castillo, Mauricio Carrión, Nelson Cevallos, Romain Palich, Valerie Pourcher, Emma Rubenstein, Pascal Migaud, Christoph Boesecke, Christian Hoffmann, Konstantinos Protopapas, Silvia Nozza, Anna Maria Cattelan, Cristina Mussini, Antonella d'Arminio Monforte, Raúl Adrian Cruz Flores, Edgar Pérez Barragán, Alma Leticia Rodríguez Guzmán, Dimie Ogoina, Nneka Marian Chika-Igwenyi, Onyeaghala Chizaram, Jenny Valverde López, Angelica García Tello, Maria Ubals, Martí Vall, Adrià Mendoza, Clara Suñer, Bonaventura Clotet, Jordi Bechini, Jose A Lepe, M. Dolores Navarro-Amuedo, Jose Ignacio Bernadino, Alba Català, Eloy José Tarín Vicente, Borja González Rodríguez, Sergi Rodriguez-Mercader, Francisca Sánchez-Martinez, Esperanza Cañas-Ruano, Laura Parra-Navarro, Finn Filén, Carmen Tallón de Lara, Dominique Braun, Vanja Piezzi, Michael Burkhard, Helen Kovari, Anja Mönch, Jake Dunning, Pedro Simoes, Achyuta Nori, Sarah Keegan, John P Thornhill, Vanessa Apea, Teymur Noori, Joyce L. Jones, Seth Judson, Elizabeth A. Gilliams, Matthew M. Hammill, Jeanne Keruly, Andrés F. Henao Martínez, Aung Lin, Jessica So, Kusha Davar, Diana Villareal, Miguel Tapia Paredes
Background: People living with HIV have accounted for 38–50% of those affected in the 2022 multicountry mpox outbreak. Most reported cases were in people who had high CD4 cell counts and similar outcomes to those without HIV. Emerging data suggest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68993eb30033f0ba5b8c934b6f628b24
https://ora.ox.ac.uk/objects/uuid:f5eac7eb-e7b9-476f-a276-23e20bc30e47
https://ora.ox.ac.uk/objects/uuid:f5eac7eb-e7b9-476f-a276-23e20bc30e47
Autor:
Kristine M Erlandson, Kathleen V Fitch, Sara A McCallum, Heather J Ribaudo, Edgar T Overton, Markella V Zanni, Gerald S Bloomfield, Todd T Brown, Carl J Fichtenbaum, Sara Bares, Judith A Aberg, Pamela S Douglas, Evelynne S Fulda, Jorge L Santana-Bagur, Jose G Castro, Laura E Moran, Vidya Mave, Khuanchai Supparatpinyo, Ponego L Ponatshego, Mauro Schechter, Steven K Grinspoon
Publikováno v:
Clin Infect Dis
Background We sought to explore multinational differences in functional status by global burden of disease (GBD) regions in the REPRIEVE cohort. Methods REPRIEVE is a prospective, double-blind, randomized, placebo-controlled, multicenter, phase III p